tiprankstipranks
Trending News
More News >
US Stem Cell Inc (USRM)
OTHER OTC:USRM
US Market

US Stem Cell (USRM) Income Statement

Compare
31 Followers

US Stem Cell Income Statement

Last quarter (Q4 2022), US Stem Cell's total revenue was $19.97K, a decrease of -15.34% from the same quarter last year. In Q4, US Stem Cell's net income was $-566.62K. See US Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 82.05K$ 200.75K$ 277.09K$ 3.07M$ 6.70M
Gross Profit
$ 58.28K$ 148.72K$ 212.97K$ 1.74M$ 4.59M
Operating Expenses
$ 1.78M$ 2.28M$ 2.61M$ 5.15M$ 5.69M
Depreciation and Amortization
$ 0.00$ 2.14M$ 1.88K$ 242.62K$ 207.13K
EBITDA
$ -2.17M$ -151.41K$ -2.40M$ -2.61M$ -508.49K
Operating Income
$ -1.72M$ -2.14M$ -2.40M$ -3.42M$ -1.10M
Other Income/Expenses
$ -1.14M$ -1.15M$ -490.25K$ -418.48K$ -1.06M
Pretax Income
$ -2.86M$ -3.29M$ -2.89M$ -3.84M$ -2.16M
Net Income
$ -2.86M$ -3.29M$ -2.89M$ -3.84M$ -2.16M
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ -0.01$ -0.01$ >-0.01
Diluted EPS
$ 0.00$ -0.01$ -0.01$ -0.01$ >-0.01
Weighted Average Shares Outstanding
591.56M 460.79M 429.29M 398.04M 365.64M
Weighted Average Shares Outstanding (Diluted)
591.56M 460.79M 429.29M 398.04M 365.64M
Currency in USD

US Stem Cell Earnings and Revenue History